NP / PA
Grant Regional Health Center, INC.
Grant Regional Health Center, INC. was paid $3.52M by Medicaid between Jan 2018 and Dec 2024, across 94 billing codes. Its largest line is 99212, Office or other outpatient visit for the evaluation and management of an established patient, straightforward — 22% of everything it billed.
33Billing provider infoGRANT REGIONAL HEALTH CENTER, INC.
LANCASTER, WI 53813
LANCASTER, WI 53813
33aNPI1255339867assigned 07/08/2005
33bProvider typePhysician Assistant
28Total paid$3.52M
24GClaims83,192
24DCodes billed94
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Physician Assistant providers in Wisconsin
Rank by total paid#1 of 147
Median peer was paid$2K
This provider vs. median2,158×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,362 | $266K | |
| 2019 | 8,900 | $350K | |
| 2020 | 9,752 | $453K | |
| 2021 | 15,793 | $618K | |
| 2022 | 13,971 | $621K | |
| 2023 | 14,370 | $659K | |
| 2024incomplete | 13,044 | $550K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 22% | 8,491 | 6,760 | $779K |
| 96361 | Intravenous infusion, hydration; each additional hour | 19% | 1,597 | 1,203 | $683K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 5,686 | 4,620 | $481K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.4% | 2,536 | 2,032 | $296K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 6.9% | 2,751 | 2,010 | $242K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 5.5% | 842 | 636 | $194K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.5% | 1,058 | 898 | $193K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.7% | 1,560 | 1,143 | $94K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 2.1% | 305 | 267 | $73K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.0% | 1,074 | 913 | $70K |
| 87631 | 1.4% | 576 | 525 | $47K | |
| 80053 | Comprehensive metabolic panel | 1.3% | 5,651 | 4,494 | $46K |
82 more codes
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,841 | $32K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,081 | $30K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 70 | $19K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,259 | $17K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 399 | $14K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,843 | $13K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 158 | $12K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 57 | $11K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,644 | $11K |
| 87507 | <1% | 34 | $10K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 136 | $10K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 235 | $7K |
| 81003 | <1% | 2,181 | $7K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 926 | $7K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,876 | $7K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 150 | $7K |
| 84484 | <1% | 1,374 | $7K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 470 | $7K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 296 | $6K |
| 80061 | Lipid panel | <1% | 578 | $6K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,447 | $6K |
| 85027 | <1% | 1,346 | $5K | |
| 83605 | <1% | 939 | $5K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,579 | $5K |
| 71045 | Radiologic examination, chest; single view | <1% | 995 | $5K |
| 86140 | <1% | 1,269 | $4K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,457 | $4K |
| 87081 | <1% | 472 | $4K | |
| 83690 | <1% | 856 | $4K | |
| G0378 | Hospital observation service, per hour | <1% | 65 | $3K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 14 | $3K |
| 73564 | <1% | 37 | $2K | |
| 85610 | <1% | 729 | $2K | |
| 81001 | <1% | 986 | $2K | |
| 86141 | <1% | 267 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 267 | $2K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 13 | $2K |
| 85379 | <1% | 376 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 61 | $2K |
| 86803 | <1% | 101 | $1K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 153 | $1K |
| 99000 | <1% | 261 | $950.29 | |
| 85007 | <1% | 305 | $872.03 | |
| 73630 | <1% | 18 | $850.39 | |
| 83880 | <1% | 84 | $849.35 | |
| 80050 | General health panel | <1% | 41 | $848.64 |
| 81025 | <1% | 113 | $779.59 | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 32 | $730.19 |
| 73610 | <1% | 13 | $629.13 | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 15 | $547.58 |
| 80305 | <1% | 49 | $403.62 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 13 | $331.28 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 13 | $331.28 |
| 83735 | <1% | 66 | $290.72 | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 13 | $272.82 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 30 | $240.37 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,642 | $197.78 |
| 82607 | <1% | 15 | $184.96 | |
| 82962 | <1% | 135 | $160.67 | |
| 87186 | <1% | 33 | $141.88 | |
| 83540 | <1% | 25 | $123.16 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 52 | $121.63 |
| 85652 | <1% | 58 | $106.96 | |
| 87077 | <1% | 13 | $74.61 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 811 | $54.49 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 928 | $54.30 |
| 82150 | <1% | 16 | $46.90 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 141 | $39.95 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 773 | $38.22 |
| J2704 | Injection, propofol, 10 mg | <1% | 290 | $31.94 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,623 | $29.51 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 16 | $10.87 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 556 | $0.14 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 249 | $0.08 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 35 | $0.00 |
| 96376 | 0% | 13 | $0.00 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 46 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 104 | $0.00 |
| A9270 | Non-covered item or service | 0% | 38 | $0.00 |
| 80320 | 0% | 15 | $0.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 305 | $0.00 |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 0% | 30 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGEHLING, JOEL (CFO)
| Provider | Location | Paid |
|---|---|---|
| Grant Regional Health Center, INC | Lancaster, WI | $153K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.